BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.

Documenti analoghi

• In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.
  di: McLaughlin, J, et al.
  Pubblicazione: (1987)
• Association of HLA antigens and BCR-ABL transcripts in leukemia patients with the Philadelphia chromosome
  di: de Carvalho, Daiana Landenberger, et al.
  Pubblicazione: (2012)
• Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.
  di: Rubin, C M, et al.
  Pubblicazione: (1988)
• Outcomes of Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias
  di: Maiti, Abhishek, et al.
  Pubblicazione: (2020)
• Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias
  di: Smith, Stephanie M., et al.
  Pubblicazione: (2021)